Pediatric Drug Research & the FDAAuthor :
Paperback
Published : Monday 4 March 2013
Description
Congress reauthorized two laws in 2007, the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA). PREA requires that sponsors conduct pediatric studies for certain products unless the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) grants a waiver or deferral. On June 20th, 2012, the House of Representatives passed, by voice vote and under suspension of the rules, the Food and Drug Administration Safety and Innovation Act, as amended. This bill would reauthorize the FDA prescription drug and medical device user fee programs, create new user fee programs for generic and biosimilar drug approvals, and make other revisions to other FDA drug and device approval processes. This book examines how many and what types of products have been studied; describes the number and type of labelling changes and FDAs review periods and describes challenges identified by stakeholders to conducting studies.
You may also like ...
by
Hardback
23 May 2024
Christian life and practice
€23.40
Extended stock – Dispatch 5-7 days
by
Hardback
18 Jul 2023
Childrens / Teenage fiction and true stories
€5.84
Extended stock – Dispatch 5-7 days
by
Paperback
24 Nov 2022
Modern and contemporary fiction: general and literary
€10.52
Extended stock – Dispatch 5-7 days
Reviews